These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 22690340)

  • 21. Circulating Tumor Cell-Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue-Based Messenger RNA Profiling Into a Noninvasive Setting.
    Lee YT; Sun N; Kim M; Wang JJ; Tran BV; Zhang RY; Qi D; Zhang C; Chen PJ; Sadeghi S; Finn RS; Saab S; Han SB; Busuttil RW; Pei R; Zhu Y; Tseng HR; You S; Yang JD; Agopian VG
    Liver Transpl; 2022 Feb; 28(2):200-214. PubMed ID: 34664394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma.
    Yu JJ; Xiao W; Dong SL; Liang HF; Zhang ZW; Zhang BX; Huang ZY; Chen YF; Zhang WG; Luo HP; Chen Q; Chen XP
    BMC Cancer; 2018 Aug; 18(1):835. PubMed ID: 30126375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved method increases sensitivity for circulating hepatocellular carcinoma cells.
    Liu HY; Qian HH; Zhang XF; Li J; Yang X; Sun B; Ma JY; Chen L; Yin ZF
    World J Gastroenterol; 2015 Mar; 21(10):2918-25. PubMed ID: 25780289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma.
    Zhou KQ; Sun YF; Cheng JW; Du M; Ji Y; Wang PX; Hu B; Guo W; Gao Y; Yin Y; Huang JF; Zhou J; Fan J; Yang XR
    EBioMedicine; 2020 Dec; 62():103107. PubMed ID: 33181461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.
    Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C
    Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating Tumor Cells as an Indicator of Treatment Options for Hepatocellular Carcinoma Less Than or Equal to 3 cm in Size: A Multi-Center, Retrospective Study.
    Zhang Q; Xia F; Gao H; Wu Z; Cao W; Xiang Q; Guan Z; Su Y; Zhang W; Chen W; Mo A; Li S
    Front Surg; 2022; 9():895426. PubMed ID: 35795230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-Specific Isolation and Instant Observation of Circulating Tumour Cell from HCC Patients via Glypican-3 Immunomagnetic Fluorescent Nanodevice.
    Chu Q; Mu W; Lan C; Liu Y; Gao T; Guan L; Fang Y; Zhang Z; Liu Y; Liu Y; Zhang N
    Int J Nanomedicine; 2021; 16():4161-4173. PubMed ID: 34168446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
    BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3D Culture of Circulating Tumor Cells for Evaluating Early Recurrence and Metastasis in Patients with Hepatocellular Carcinoma.
    Hu CL; Zhang YJ; Zhang XF; Fei X; Zhang H; Li CG; Sun B
    Onco Targets Ther; 2021; 14():2673-2688. PubMed ID: 33888992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma.
    Guo W; Sun YF; Shen MN; Ma XL; Wu J; Zhang CY; Zhou Y; Xu Y; Hu B; Zhang M; Wang G; Chen WQ; Guo L; Lu RQ; Zhou CH; Zhang X; Shi YH; Qiu SJ; Pan BS; Cao Y; Zhou J; Yang XR; Fan J
    Clin Cancer Res; 2018 May; 24(9):2203-2213. PubMed ID: 29374055
    [No Abstract]   [Full Text] [Related]  

  • 31. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
    Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
    Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients.
    Zhao X; Zhao J; Tao L; Pan Y; Yang L; Zhang X; Yuan J; Zhu H
    J Gastrointest Oncol; 2021 Dec; 12(6):3050-3060. PubMed ID: 35070429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma.
    Yu J; Wang Z; Zhang H; Wang Y; Li DQ
    World J Gastroenterol; 2021 Nov; 27(43):7546-7562. PubMed ID: 34887648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
    Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection.
    von Felden J; Schulze K; Krech T; Ewald F; Nashan B; Pantel K; Lohse AW; Riethdorf S; Wege H
    Oncotarget; 2017 Oct; 8(52):89978-89987. PubMed ID: 29163804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation.
    Wang PX; Xu Y; Sun YF; Cheng JW; Zhou KQ; Wu SY; Hu B; Zhang ZF; Guo W; Cao Y; Huang XW; Zhou J; Fan J; Yang XR
    Liver Int; 2021 Mar; 41(3):562-573. PubMed ID: 33205544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of circulating tumor cell enumeration and tumor marker detection in predicting prognosis and treatment effect in metastatic castration-resistant prostate cancer.
    Chang K; Kong YY; Dai B; Ye DW; Qu YY; Wang Y; Jia ZW; Li GX
    Oncotarget; 2015 Dec; 6(39):41825-36. PubMed ID: 26497689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of Circulating Tumor Cells to Track Hepatocellular Carcinoma Progression After Liver Transplantation-Case Report.
    Deng Y; Sun L; Liang H; Cui B; Cui C; Zhao D; Wan A; Wan G
    Front Oncol; 2021; 11():760765. PubMed ID: 34745999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research progress on circulating tumor cells of hepatocellular carcinoma.
    Wan C; Zhou B
    J Interv Med; 2021 Nov; 4(4):181-183. PubMed ID: 35586377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Epithelial Cell Adhesion Molecule-Positive Circulating Tumor Cell Count Predicts Poor Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization.
    Shen J; Wang WS; Zhu XL; Ni CF
    J Vasc Interv Radiol; 2018 Dec; 29(12):1678-1684. PubMed ID: 30392801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.